{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:16Z","timestamp":1761919216853},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.cancergencyto.2008.09.016","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T10:00:35Z","timestamp":1232704835000},"page":"63-67","source":"Crossref","is-referenced-by-count":7,"title":["Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib"],"prefix":"10.1016","volume":"189","author":[{"given":"Philippe","family":"Schafhausen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Dierlamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim H.","family":"Bruemmendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel R.","family":"Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Schnittger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.09.016_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.leu.2403607","article-title":"Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha","volume":"19","author":"Bacher","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/cncr.22936","article-title":"The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells","volume":"110","author":"Deininger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3324\/haematol.11064","article-title":"Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure","volume":"92","author":"Fabarius","year":"2007","journal-title":"Haematologica"},{"issue":"108","key":"10.1016\/j.cancergencyto.2008.09.016_bib5","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","article-title":"(2006) Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia","author":"Kovitz","year":"2006","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.cancergencyto.2008.09.016_bib6","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.leukres.2003.10.017","article-title":"Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission","volume":"28","author":"Mauro","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib7","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2403037","article-title":"Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case","volume":"17","author":"Mozziconacci","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2004.05215.x","article-title":"Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance?","volume":"127","author":"O'Shea","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib9","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V83.10.2780.2780","article-title":"The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation","volume":"83","author":"Pedersen-Bjergaard","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib10","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","article-title":"Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia","volume":"18","author":"Terre","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.09.016_bib11","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.042702899","article-title":"Genomic DNA breakpoints in AML1\/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia","volume":"99","author":"Zhang","year":"2002","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808005773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808005773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:39:26Z","timestamp":1589503166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460808005773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0165460808005773"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.09.016","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}